Clinical experience with the novel levodopa formulation entacapone + levodopa + carbidopa (Stalevo).
about
Selegiline orally disintegrating tablets for the treatment of Parkinson's disease.Optimizing levodopa therapy for Parkinson's disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective.Immediate versus delayed switch from levodopa/carbidopa to levodopa/carbidopa/entacapone: effects on motor function and quality of life in patients with Parkinson's disease with end-of-dose wearing off.Levodopa infusion does not decrease the onset of abnormal involuntary movements in parkinsonian rats.
P2860
Clinical experience with the novel levodopa formulation entacapone + levodopa + carbidopa (Stalevo).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Clinical experience with the n ...... evodopa + carbidopa (Stalevo).
@ast
Clinical experience with the n ...... evodopa + carbidopa (Stalevo).
@en
type
label
Clinical experience with the n ...... evodopa + carbidopa (Stalevo).
@ast
Clinical experience with the n ...... evodopa + carbidopa (Stalevo).
@en
prefLabel
Clinical experience with the n ...... evodopa + carbidopa (Stalevo).
@ast
Clinical experience with the n ...... evodopa + carbidopa (Stalevo).
@en
P2860
P356
P1476
Clinical experience with the n ...... evodopa + carbidopa (Stalevo).
@en
P2093
Dee E Silver
P2860
P304
P356
10.1586/14737175.4.4.589
P577
2004-07-01T00:00:00Z